Cumberland Pharmaceuticals Full Year 2024 Earnings: US$0.46 loss per share (vs US$0.44 loss in FY 2023)
US$6.48m (loss widened by 3.2% from FY 2023). US$0.46 loss per share (further deteriorated from US$0.44 loss in FY 2023).
Finanznachrichten5d
Biodexa Pharmaceuticals PLC: Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP
The planned registrational Phase 3 study of eRapa in FAP will be a double-blind placebo-controlled trial in 168 patients ... Biodexa's headquarters and R&D facility is in Cardiff, UK. For more ...
AC Immune SA: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update Landmark exclusive option and license deal with Takeda for ACI-24.060 with $100 million upfront and additional potent ...
edie6d
Mercedes’ sustainable carbon fibre project and Channel 4’s B-Corp competition: The sustainability success stories of the week
Discover how leading businesses are tackling sustainability. From solar energy to sustainable pallets, explore eco-friendly ...
The best sleep tracking app for 2025, tested and reviewed by a certified sleep coach
Sleep tracking apps can help improve your sleep quality over time, if you use the data to hone your bedtime habits. We had a ...
Key Training Phases Every Runner Should Complete Before Race Day
Use this guide to better understand how navigate each phase of training for a race, based on your experience level.
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update Landmark exclusive option and license deal with Takeda for ACI-24.060 with $100 million upfront and additional ...
Janes4d
UK FSS programme charts propulsion FAT milestones
The Fleet Solid Support Ship (FSS) programme for the UK Royal Fleet Auxiliary (RFA) has chalked up new milestones with the ...
Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD
CRO" running radically faster, more reliable clinical trials for life science pioneers, and Sooma Medical, a world-leading provider of effective brain stimulation treatments for psychiatric and ...